Deck

MetLife, Inc. · MET · NYSE

MetLife is a $77B-revenue, $745B-asset global multi-line insurer that earns spread on a $500B+ general-account portfolio, underwrites U.S. group benefits and pension risk transfer, and runs a $736B institutional asset manager called MIM.

$80.91
Price (5/7/2026)
$53B
Market cap
$77B
Revenue (FY25)
$736B
MIM Total AUM (Q1 26)
Listed 2000 at $13; hit $11 in March 2009, $24 in March 2020, then a $88 all-time high in November 2024 — chopping in a $70–87 range since, now $81.
2 · The tension

A 16% adjusted ROE on a metric the comp committee redefined twice in two years

  • Two redefinitions, both favorable. Q4 2024 redefined adjusted ROE to exclude AOCI; Q4 2025 redefined adjusted earnings to exclude wholly-owned real-estate depreciation, worth roughly $200M of annual benefit. Both moves favor the metric the long-term incentive plan is paid against.
  • The wedge IS the valuation. Core adjusted ROE prints at 16.0% — inside the New Frontier 15–17% target band. GAAP ROE is 12.9%. The 1.82× P/B premium to Prudential's 1.21× is paid for the 16.0% number, not the 12.9% one.
  • Pay rose as earnings fell. CEO Khalaf's 2025 total comp climbed 10% to $22.4M while GAAP net income to common dropped from $4.23B to $3.17B and reported ROE compressed from 16.9% to 12.9%. The cash bonus was flat — the raise came from the equity grant tied to the redefined operating metrics.
The wedge between 16.0% adjusted ROE and 12.9% GAAP ROE is the gap the multiple-expansion thesis requires to close.
3 · Soft signals beneath the Q1 beat

Q1 2026 cleared consensus — three lines underneath say wait for Q2

+58%
Variable inv. income Q1 2026 YoY ($518M)
32%
Of FY26 VII guide used in one quarter
-$0.9B
U.S. statutory capital QoQ ($17.1B → $16.2B)
+75%
Mortgage ACL FY25 ($461M → $807M)

Adjusted EPS of $2.42 beat consensus (~$2.25–$2.27), but the move was concentrated. Variable investment income — a private-equity mark line that came in below the 2025 Business Plan goal — supplied roughly 60% of the year-on-year improvement and burned a third of the full-year ~$1.6B pre-tax guide in three months. Statutory capital fell $900M in the same quarter the company returned $1.1B to shareholders, while the mortgage allowance on a 38.9%-office, $42.4B commercial book climbed 75% over FY25. Q2 (early August, consensus adjusted EPS ~$2.50) is the first clean run-rate test.

4 · The bull lever

An asset manager priced as an insurance subsidiary

  • $736B AUM and accelerating. The PineBridge close on Dec 30, 2025 lifted Total AUM to $736.3B (+22% YoY at Q1 26) and added institutional alts capability. Q1 2026 MIM adjusted earnings rose 68% YoY to $47M; FY25 jumped 61% to $200M. New Frontier targets $1T AUM by 2029.
  • Insurance multiple, asset-manager economics. Management guides $240–280M for FY26 MIM earnings. At scale, $400–500M of fee earnings is the kind of stream that institutional asset-manager peers like PGIM trade at 15–20× — versus the 8–9× consolidated insurance multiple the market applies to the whole company today.
  • The disclosure unlock sits in December. MIM became a reportable segment in Q4 2025, but standalone fee margins, organic flow, and distribution economics are not broken out. The December 2026 Investor Day is where management can — or won't — frame MIM as the standalone franchise the bull case prices.
Strip MIM out at 17× earnings and roughly $10 per share of hidden value would sit inside today's 9× consolidated multiple.
5 · Bull & Bear

Watchlist — wait for one clean print on stable definitions before committing

  • For. Diluted share count fell 41% from 1.14B (FY14 weighted-average) to 673M (FY25 weighted-average) with zero equity issuance through COVID, the rate shock, and LDTI. An 8.4% combined shareholder yield on a 12% ROE business compounds book value per share regardless of the macro tape.
  • For. Management cleared all four Next Horizon 2019–2024 commitments. New Frontier Year One hit its ROE, EPS-growth, FCF and expense-ratio targets, and Q1 2026 adjusted EPS of $2.42 annualizes above the $9.88 FY26 consensus.
  • Against. 2.83× tangible book is the highest multiple MET has worn in a decade — pre-LDTI it traded 0.7–1.1× from 2014 to 2020 — and the premium is paid for a 16.0% adjusted ROE the comp committee defined, not the 12.9% GAAP ROE delivered.
  • Against. Five-year capital return of ~$24.6B exceeded ~$20.5B of cumulative GAAP net income, holdco liquid assets ended FY25 at $3.6B (well below recent-year peaks), and PE-backed reinsurers (Athene, Brookfield, Global Atlantic) are compressing spread on the $42.4B CML book where the allowance jumped 75% last year.
My view — the bear carries slightly more weight today because the price embeds plan execution that has not cleared two clean prints on stable definitions. Lean long if FY26 adjusted EPS clears $10 with no further metric redefinition; avoid on a third Q4 redefinition or year-end ACL above $1.2B.

Watchlist to re-rate: Q2 2026 earnings in early August (consensus adjusted EPS ~$2.50) — does VII normalize toward the implied ~$400M post-tax run-rate; June 2026 say-on-pay vote and any proxy-advisor pushback on the redefined Core perimeter; year-end 2026 mortgage ACL trajectory and any FY26 metric redefinition.